Powerful Whole Exome Sequencing for Variant Discovery
Whole exome sequencing (WES) enables the discovery and assessment of genetic variations linked to rare or complex diseases and is a key tool for the diagnosis of genetic disease, population genome studies, and tumor-normal sequencing protocols used in precision oncology. With high accuracy and unparalleled flexibility, the G4 Platform delivers reliable WES results with industry-leading speed.
Unparalleled Speed, Power and Operational Flexibility
The G4 Sequencing Platform offers unmatched flexibility, while delivering faster results with high accuracy. The platform is a plug-and-play solution, seamlessly integrating into existing sequencing workflows and laboratory ecosystems.
Key WES capabilities:
- Rapid SBS enables cost-efficient overnight delivery of 8–64 exome samples in 16-19 hours.*
- The G4 delivers highly accurate exome data comparable to leading platforms with SNP and INDEL F1scores at 99% and 95% respectively.
*Assuming 34 MB, ~100x coverage
Performance Characterization of the G4 for Whole Exome Sequencing
The whole exome sequencing application note highlights the capability for the G4 to deliver accurate results comparable with industry-leading platforms with more speed and added flexibility.
